Live MD Anderson Cancer Center News with Latest Updates

Live MD Anderson Cancer Center news and developments with the latest updates. Check out current MD Anderson Cancer Center news stories and find out what happened, what is going on with MD Anderson Cancer Center. Recent news updates about MD Anderson Cancer Center
San Antonio luncheon to honor former U.S. Sec. of State Rex Tillerson
MD Anderson, Artios Pharma and ShangPharma announce in-licensing agreement for DNA damage response inhibitor
MD Anderson and Takeda Announce Collaboration to Accelerate Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program
MD Anderson and Varian partner to optimize radiation oncology treatment
MD Anderson expanding its presence in Woodlands
Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations
PARP inhibitor plus chemotherapy improves progression-free survival for advanced ovarian cancer patients
Study shows nearly half of cancer patients who enter a comprehensive tobacco treatment program quit smoking
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer
In Memory of T. Boone Pickens
MD Anderson receives $55 million over five years in comprehensive cancer center status renewal
MD Anderson receives more than $19 million in CPRIT funding
Boehringer Ingelheim and MD Anderson form unique virtual research and development center to rapidly advance new cancer therapies
Bacteria on tumors influences immune response and survival of patients with pancreatic cancer
MD Anderson to expand Proton Therapy Center